This piece originally appeared in the Timmerman Report
We’re entering uncharted waters in the US government. I don’t think it’s hyperbolic to say there will be new regulations, new laws that we’ve never seen before. While I don’t pretend to understand the new administration in any way, I do expect there will be more chaos at the level of policy-making than we’ve seen in decades and one thing that chaos does is it increases the likelihood of extreme outcomes.
So here is one speculative policy idea:
I think we should trade the 12-year exclusivity period from biologics to small molecule drugs. Continue reading